Gregory M Lucas1, Mohamed G Atta, Katie Zook, Allison M McFall, Shruti H Mehta, Derek M Fine, James H Stein, George J Schwartz. 1. aDepartment of Medicine, Johns Hopkins University School of Medicine bDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland cDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison Wisconsin dDepartment of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.
Abstract
BACKGROUND: Monitoring kidney function is important in HIV-positive persons, but creatinine-based estimates of glomerular filtration rate (GFR) have limitations. There are little to no data available assessing GFR trends in HIV-positive persons using a gold-standard measure of GFR. METHODS: We measured GFR based on iohexol plasma disappearance (iGFR) annually for 3 years in nondiabetic, HIV-negative and HIV-positive volunteers with normal estimated kidney function. We used mixed linear models to evaluate factors associated with baseline iGFR and iGFR slope. RESULTS: One hundred HIV-negative and 191 HIV-positive, predominantly black individuals (median age 49 years) participated in the study and completed a total of 960 iGFR assessments over a median of 36 months. Despite similar estimated GFR at baseline, average iGFR values were lower in HIV-positive compared with HIV-negative participants (103.2 vs. 110.8, ml/min/1.73 m, P = 0.004). However, subsequent iGFR slope was not significantly different in HIV-positive and HIV-negative participants. In the HIV-positive group, the presence of carotid plaque and hepatitis C virus coinfection were associated with significantly lower iGFR values at baseline. A nonsuppressed HIV RNA level at baseline was associated with a significantly more rapid iGFR decline compared with individuals with HIV RNA less than 400 copies/ml (-4.69 vs. -1.31 ml/min per 1.73 m per year, P = 0.005). Other factors significantly associated with iGFR slope included albuminuria and glycosylated hemoglobin. CONCLUSION: Compared with HIV-negative persons, HIV-positive participants had significantly lower baseline iGFR, despite similar estimated GFR in the two groups. Nonsuppressed HIV RNA at baseline was associated with a more rapid iGFR decline over 3 years.
BACKGROUND: Monitoring kidney function is important in HIV-positive persons, but creatinine-based estimates of glomerular filtration rate (GFR) have limitations. There are little to no data available assessing GFR trends in HIV-positive persons using a gold-standard measure of GFR. METHODS: We measured GFR based on iohexol plasma disappearance (iGFR) annually for 3 years in nondiabetic, HIV-negative and HIV-positive volunteers with normal estimated kidney function. We used mixed linear models to evaluate factors associated with baseline iGFR and iGFR slope. RESULTS: One hundred HIV-negative and 191 HIV-positive, predominantly black individuals (median age 49 years) participated in the study and completed a total of 960 iGFR assessments over a median of 36 months. Despite similar estimated GFR at baseline, average iGFR values were lower in HIV-positive compared with HIV-negative participants (103.2 vs. 110.8, ml/min/1.73 m, P = 0.004). However, subsequent iGFR slope was not significantly different in HIV-positive and HIV-negative participants. In the HIV-positive group, the presence of carotid plaque and hepatitis C virus coinfection were associated with significantly lower iGFR values at baseline. A nonsuppressed HIV RNA level at baseline was associated with a significantly more rapid iGFR decline compared with individuals with HIV RNA less than 400 copies/ml (-4.69 vs. -1.31 ml/min per 1.73 m per year, P = 0.005). Other factors significantly associated with iGFR slope included albuminuria and glycosylated hemoglobin. CONCLUSION: Compared with HIV-negative persons, HIV-positive participants had significantly lower baseline iGFR, despite similar estimated GFR in the two groups. Nonsuppressed HIV RNA at baseline was associated with a more rapid iGFR decline over 3 years.
Authors: James H Stein; Claudia E Korcarz; Maureen E Mays; Pamela S Douglas; Mari Palta; Hongling Zhang; Tamara Lecaire; Diane Paine; David Gustafson; Liexiang Fan Journal: J Am Soc Echocardiogr Date: 2005-03 Impact factor: 5.251
Authors: Amandine Gagneux-Brunon; Pierre Delanaye; Nicolas Maillard; Anne Fresard; Thierry Basset; Eric Alamartine; Frédéric Lucht; Hans Pottel; Christophe Mariat Journal: AIDS Date: 2013-06-19 Impact factor: 4.177
Authors: Alison G Abraham; Keri N Althoff; Yuezhou Jing; Michelle M Estrella; Mari M Kitahata; C William Wester; Ronald J Bosch; Heidi Crane; Joseph Eron; M John Gill; Michael A Horberg; Amy C Justice; Marina Klein; Angel M Mayor; Richard D Moore; Frank J Palella; Chirag R Parikh; Michael J Silverberg; Elizabeth T Golub; Lisa P Jacobson; Sonia Napravnik; Gregory M Lucas Journal: Clin Infect Dis Date: 2014-11-18 Impact factor: 9.079
Authors: Derek K Ng; Lisa P Jacobson; Todd T Brown; Frank J Palella; Jeremy J Martinson; Robert Bolan; Edgar R Miller; George J Schwartz; Alison G Abraham; Michelle M Estrella Journal: AIDS Date: 2014-01-28 Impact factor: 4.177
Authors: Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian Journal: Clin Infect Dis Date: 2014-09-17 Impact factor: 9.079
Authors: Gregory M Lucas; Yuezhou Jing; Mark Sulkowski; Alison G Abraham; Michelle M Estrella; Mohamed G Atta; Derek M Fine; Marina B Klein; Michael J Silverberg; M John Gill; Richard D Moore; Kelly A Gebo; Timothy R Sterling; Adeel A Butt Journal: J Infect Dis Date: 2013-07-31 Impact factor: 5.226
Authors: Lars Peters; Daniel Grint; Jens D Lundgren; Jürgen K Rockstroh; Vincent Soriano; Peter Reiss; Anna Grzeszczuk; Helen Sambatakou; Amanda Mocroft; Ole Kirk Journal: AIDS Date: 2012-09-24 Impact factor: 4.177
Authors: Lesley A Inker; Christina Wyatt; Rebecca Creamer; James Hellinger; Matthew Hotta; Maia Leppo; Andrew S Levey; Aghogho Okparavero; Hiba Graham; Karen Savage; Christopher H Schmid; Hocine Tighiouart; Fran Wallach; Zipporah Krishnasami Journal: J Acquir Immune Defic Syndr Date: 2012-11-01 Impact factor: 3.731
Authors: Joseph B Margolick; Lisa P Jacobson; George J Schwartz; Alison G Abraham; Annie T Darilay; Lawrence A Kingsley; Mallory D Witt; Frank J Palella Journal: PLoS One Date: 2014-02-07 Impact factor: 3.240
Authors: Andreas Deckert; Florian Neuhann; Christina Klose; Thomas Bruckner; Claudia Beiersmann; John Haloka; Mannie Nsofwa; Greg Banda; Maik Brune; Helmut Reutter; Dietrich Rothenbacher; Martin Zeier Journal: PLoS One Date: 2017-09-20 Impact factor: 3.240